April Wang

April focuses her practice on initial public offerings on the Hong Kong Stock Exchange and Hong Kong listing rules and securities regulations compliance advisory work.

April is a native Mandarin speaker and is fluent in English and Cantonese.

Representative matters:

Capital Markets

• MetaLight Inc., a leading time series data intelligence service provider in China’s public bus sector, on its HK$242 million IPO on HKEX
• Joint sponsors and underwriters CICC and CMB International Securities on HK$$1.005 billion IPO and listing of Zenergy, a lithium-ion battery manufacturer focusing on the research and development, production and sales of electric vehicle battery products, electrochemical energy storage battery products and aviation battery products.
• Joint sponsors and underwriters CICC and SPDB International on HK$583 million Hong Kong IPO of BrainAurora Medical Technology, a seasoned player in China's cognitive impairment digital therapeutics (DTx) market
• YH Entertainment, the largest artist management company in China, on its HK$490 million IPO on HKEX
• GOGOX, an online intracity logistics platform, on its HK$670.8 million Hong Kong IPO
• Sponsor CICC in Laekna Therapeutics’ US$101 million Hong Kong IPO 
• Sponsor and underwriters in the Hong Kong IPO of Litian Pictures Holdings Limited, a leading drama series distribution company in China
• Raily Aesthetic Medicine International Holdings Limited, a leading aesthetic medical service provider in China, on its Hong Kong IPO
• FriendTimes Inc., a leading mobile game developer in China, on its Hong Kong IPO
• Sponsor and underwriters in the Hong Kong IPO of Cheshi Holdings Limited, a leading online automobile trading service provider in China
• Sponsor and underwriters in the Hong Kong IPO of Litian Pictures Holdings Limited, a leading drama series distribution company in China

Compliance

• Asymchem (6821.HK) on its post-listing compliance matter
• GOGOX (2246.HK) on its post-listing compliance matter
• YH Entertainment (2306.HK) on its post-listing compliance matter
• Akeso (9926.HK) on its post-listing compliance matter

Others

• Akeso on its HK$1.2 billion follow-on offering and HK$1.942 billion secondary follow-on offering